Vogt, B <br/><br/>
Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: results of a 12-month multicenter, open-label, prospective study.  [electronic resource] 

 -  Transplantation proceedings  Jun 2006 
 - 1301-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2006.02.125  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Creatinine--metabolism<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Kidney Function Tests<br/>Kidney Transplantation--immunology<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--administration & dosage<br/>Safety<br/>Tablets, Enteric-Coated<br/>Time Factors<br/>Treatment Failure<br/>Treatment Outcome